Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > WHO Declares Monkeypox as a Global Public Health Emergency

<< Previous

Bullboard Posts

Next >>

Comment by IvanVanBeethovenon Jul 29, 2022 9:18am

197 Views

Post# 34859592

RE:WHO Declares Monkeypox as a Global Public Health Emergency

The "ordinary" smallpox were eradicated in the 1970s through a successful worldwide vaccination campaign. Those who have been vaccinated also enjoy protection against monkeypox. This variant is also lighter than regular pox!
Allthough Theralase has most likely a very effective 'inactivated virus' vaccine in the pipeline, this will not cause much excitement as very effective vaccines already exist (cfr. Bavarian Nordic wins EU approval)
But I would be glad to be wrong!

regards
Ivan

<< Previous

Bullboard Posts

Next >>

Meet Canopy USA’s new CEO, Brooks Jorgensen